Business Wire

A Limited Collection Team-up Between High-end Streetwear Brand LIBERE and Naruto Is Set for Release!

Share

A new limited collection teaming up Japanese high-end streetwear brand LIBERE and Naruto is scheduled for release in May.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210420006240/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

LIBERE characters (Graphic: Business Wire)

The theme of the collection is “LIBERE FOR NARUTO” – a series of garments created around the unique points of each character, with the concept of characters of the Naruto world wearing the LIBERE clothing line.

Known for its style bringing together diverse elements, in this collection LIBERE suggests a new “street ninja style.” By making liberal use of the clan marks and colorings of 6 major characters: Naruto, Sasuke, Sakura, Kakashi, Shikamaru, and Itachi, the collection achieves a strong affinity with the characters. The collection includes minute details such as straps, pockets, and zippers, featuring high-function reflective surfaces as well as tactical jackets and pants that epitomize ninja fashion. Each item includes extras manufactured especially for the collection, such as tags, plastic bags, and dust covers.

Additionally, an original art lookbook has been created by Pierrot, the animation studio that brought to life the anime Naruto: Shippuuden, depicting the characters in their everyday attire to further link anime and reality within the collection.
*The original art poster will be given out as a present to those who purchase the collaboration products.

All products will receive an advanced release at the LIBERE official online store and shops carrying LIBERE products from April 22. (World shipping)

An event commemorating the release of the collection is planned to be held in Tokyo in mid-May. *There is a possibility of change or cancellation depending on the circumstances. (For detailed event information, please visit the official website or Instagram account.)

[LIBERE]
Centered on designs from the creative team Maverick Creative, LIBERE realizes designs mixing diverse styles ranging from high-end street to military/work and sports, then adding unique details to achieve a totally unique look. The brand offers the hottest styles that can be found nowhere else.

• OFFICIAL WEBSITE
https://www.libere-official.com/
• INSTAGRAM
https://www.instagram.com/libere_official/

(C) Masashi Kishimoto, Scott/Shueisha, TV TOKYO, Pierrot & LIBERE®

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

ROOMS CO.,LTD.
FUYU HAMADA
TEL : 81(0)3-3352-5100
FAX : 81(0)3-3354-3810
Mail : hamada@c-rooms.co.jp

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye